Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Escalier Biosciences BV

www.escalierbio.com

Latest From Escalier Biosciences BV

Venture Funding Deals: MedImmune Spinout Viela Lands $250m Series A

China's JW Therapeutics nets $90m for cancer cell therapy, including backing from biotechs Celgene and WuXi. Meanwhile, Foghorn sounds out a $50m A round for its gene trafficking technology applications.

Deals Financing
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
  • Therapeutic Areas
  • Dermatology
  • Immune Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Netherlands
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Escalier Biosciences BV
  • Senior Management
  • Raju Mohan, PhD, CEO
    Esther van den Boom, CFO
    Chris Krueger, CBO
    Allison Luo, MD, CMO
    John Nuss, PhD, CSO
  • Contact Info
  • Escalier Biosciences BV
    Transistorweg 5J
    Nijmegen, 6534 AT
    Netherlands
Advertisement
Advertisement
UsernamePublicRestriction

Register